Aftonos

Afton Scientific is an established US-based CDMO specializing in aseptic fill-finish services for sterile injectable pharmaceuticals. The company has a strong track record of regulatory compliance and quality assurance. It serves pharmaceutical and biopharmaceutical companies by providing end-to-end aseptic manufacturing solutions for both biologics and small molecules. In 2024, it announced a $200 million expansion to increase capacity and implement new technologies at its Virginia facility. The company received a majority investment from Arlington Capital Partners in January 2024 but remains independently operated under its original brand.